- ►diabetesjournals.org DR Cryer, SP Nicholas, DH Henry, DJ Mills, … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—The Comparative Outcomes Study of Metformin
Intervention versus Conventional (COSMIC) Approach Study was a randomized,
open-label, active-comparator, parallel-group, 1-year trial in type 2 ... Cited by 38 - Related articles - All 5 versions
R Rachmani, I Slavachevski, Z Levi, BS Zadok … - European Journal of Internal Medicine, 2002 - Elsevier Background: The strict limiting criteria for the use of metformin in diabetes
mellitus stem largely from reports, in the 1970s, of mortality and lactic
acidosis associated with phenformin. Data about metformin are less clear ... Cited by 44 - Related articles - All 5 versions
A Holstein, M Stumvoll - Diabetologia, 2005 - Springer Abstract Metformin is an effective anti-hyperglycaemic and cardioprotective
agent, but a long list of contraindi- cations precludes millions of patients
with type 2 diabetes from using it. This is largely due to the historical ... Cited by 61 - Related articles - BL Direct - All 3 versions
AM Stades, JT Heikens, DW Erkelens, F … - Journal of internal medicine, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 55 - Related articles - BL Direct - All 5 versions
- ►karolinskauniversitetssjukhuset.se [PDF] SR Salpeter, E Greyber, GA Pasternak, EE … - Archives of Internal Medicine, 2003 - archinte.highwire.org Methods A comprehensive search was performed to identify all comparative trials
or observational cohort studies published between January 1, 1959, and March 31,
2002, that evaluated metformin therapy, alone or in combination with other ... Cited by 322 - Related articles - BL Direct - All 16 versions
AA Tahrani, GI Varughese, JH Scarpello, … - Bmj, 2007 - bmjcom.highwire.org You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 18 - Related articles - BL Direct - All 4 versions
SE Inzucchi - Diabetes Care, 2005 - Am Diabetes Assoc Throughout the world and for many years, metformin has been a mainstay of
therapy for patients with type 2 diabetes. This highly effective and usually
well-tolerated oral agent is, to date, the only one demonstrated to reduce ... Cited by 35 - Related articles - BL Direct - All 7 versions
J McCormack, K Johns, H Tildesley - Canadian Medical Association Journal, 2005 - ecmaj.ca The conclusions from the UKPDS and from a recent meta-analysis have been
debated. 8 , 9 , 10 It is important to remember, though, that the benefit from
using metformin in the UKPDS was observed among patients with newly ... Cited by 37 - Related articles - BL Direct - All 12 versions
